ASSET PURCHASE AGREEMENT among MEDICIS PHARMACEUTICAL CORPORATION, a Delaware corporation, ASCENT PEDIATRICS, INC., a Delaware corporation, BIOMARIN PHARMACEUTICAL INC., a Delaware corporation and BIOMARIN PEDIATRICS INC., a Delaware corporationAsset Purchase Agreement • June 2nd, 2004 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 2nd, 2004 Company Industry JurisdictionThis Asset Purchase Agreement is entered into as of April 20, 2004, by and among Medicis Pharmaceutical Corporation, a Delaware corporation (“Medicis”), Ascent Pediatrics, Inc., a Delaware corporation (“Ascent”), BioMarin Pharmaceutical Inc., a Delaware corporation (“BioMarin”), and BioMarin Pediatrics Inc., a Delaware corporation and wholly-owned subsidiary of BioMarin (“BioMarin Acquisition”). Capitalized terms used in this Agreement are defined herein and in Exhibit A.
LICENSE AGREEMENTLicense Agreement • June 2nd, 2004 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 2nd, 2004 Company Industry JurisdictionThis LICENSE AGREEMENT (“Agreement”) is entered into as of May 18, 2004 (the “Effective Date”) by and among BioMarin Pharmaceutical Inc., a Delaware corporation (“BioMarin”), BioMarin Pediatrics Inc., a Delaware corporation and wholly-owned subsidiary of BioMarin (“BioMarin Acquisition” or “Licensee”), Medicis Pharmaceutical Corporation, a Delaware corporation (“Medicis”), and Ascent Pediatrics, Inc., a Delaware corporation (“Ascent” or “Licensor”), a wholly-owned subsidiary of Medicis. Each is referred to herein as a “Party” and collectively as the “Parties.”
SECURITIES PURCHASE AGREEMENT among MEDICIS PHARMACEUTICAL CORPORATION, a Delaware corporation, ASCENT PEDIATRICS, INC., a Delaware corporation, BIOMARIN PHARMACEUTICAL INC., a Delaware corporation and BIOMARIN PEDIATRICS INC., a Delaware corporation...Securities Purchase Agreement • June 2nd, 2004 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 2nd, 2004 Company Industry JurisdictionThis Securities Purchase Agreement is entered into as of May 18, 2004 (the “Effective Date”), by and among Medicis Pharmaceutical Corporation, a Delaware corporation (“Medicis”), Ascent Pediatrics, Inc., a Delaware corporation (“Ascent”), BioMarin Pharmaceutical Inc., a Delaware corporation (“BioMarin”), and BioMarin Pediatrics Inc., a Delaware corporation and wholly-owned subsidiary of BioMarin (“BioMarin Acquisition”). Capitalized terms used in this Agreement are defined herein and in Exhibit A.